Title : Sorafenib alone or as combination therapy for growth control of cholangiocarcinoma.

Pub. Date : 2007 May 1

PMID : 17266941






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The novel multi-kinase inhibitor sorafenib potently suppresses the growth of various cancers by inhibiting kinases of wild-type B-Raf, mutant(V559E)B-Raf and C-Raf but its effects on CC remains to be explored. Sorafenib B-Raf proto-oncogene, serine/threonine kinase Homo sapiens
2 The novel multi-kinase inhibitor sorafenib potently suppresses the growth of various cancers by inhibiting kinases of wild-type B-Raf, mutant(V559E)B-Raf and C-Raf but its effects on CC remains to be explored. Sorafenib B-Raf proto-oncogene, serine/threonine kinase Homo sapiens